Avacta Group PLC (AVCT)

Industry Biotechnology
This stock can be held in an Investment ISA, SIPP and Investment Account
Sell

73.00p

Buy

75.00p

arrow-down-1.00p (-1.33%)

Prices updated at 24 Sep 2026, 17:05 BST
| Prices minimum 15 mins delay
|
Prices in GBX
Avacta Group PLC is a clinical-stage life sciences company expanding the reach of potent cancer therapies with the pre-CISION platform. pre-CISION is a proprietary warhead delivery system based on a tumor-specific protease (fibroblast activation prote ...
FTSE All-Share
arrow-down-0.3%
LSE
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
our Investment Fees and Charges.

logo In the news

Sharecast service unavailable

logo Press releases

16 Sep 2026

14 Sep 2026

04 Sep 2026

01 Sep 2026

09 Jul 2026

08 Jul 2026

25 Jun 2026

25 Jun 2026

23 Jun 2026

22 Jun 2026

logo Key dates

Forecast date
Annual general meetingJun 2027
Annual reportMay 2027
Final resultsMay 2027
Half yearly resultsSep 2026
Previous date
Annual general meetingJun 2026
Annual reportMay 2026
Final resultsMay 2026
Half yearly resultsSep 2025

logo Company reports

31 Dec 2025
Annual Report doc-arrow-d
30 Jun 2025
Quarterly Report doc-arrow-d


Important Information

Investment values, and income from investments, can go down as well as up, so you may get back less than you invest. This is not a personal recommendation for a specific investment. If you're not sure which investments are suitable for you, consult Fidelity's advisers or another authorised financial adviser.

© Copyright 2026 Morningstar. All rights reserved. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.

The ESG-related information, methodologies, tools, ratings, data and opinions contained or reflected herein are not directed to or intended for use or distribution to India-based clients or users and their distribution to Indian resident individuals or entities is not permitted, and Morningstar accepts no responsibility or liability whatsoever for the actions of third parties in this respect.